Lumakras

Do you want to link to this Amgen Site and leave Amgen.co.kr?

YOU ARE NOW LEAVING AMGEN KOREA'S WEB SITE. Amgen Korea takes takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Lumakras® tablet 120mg(sotorasib) 

  • Product Name (Korean) 루마크라스정® 120mg(소토라십)
  • Product Name (English) LUMAKRAS® tablet 120mg(sotorasib)
  • Active Ingredient (Korean) 소토라십
  • Active Ingredient (English) Sotorasib
  • API content 120mg
  • Excipients Microcrystalline cellulose, Lactose monohydrate, Croscarmellose sodium, Magnesium stearate, Opadry II Yellow(85F120132)
  • Treatment Anticancer
  • Indications

    Treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), who have received at least one prior therapy

  • Lumakras® Medication Guide